{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:33Z","timestamp":1773298113555,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2019.00257","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T04:38:10Z","timestamp":1571373490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Indomethacin Enhances Type 1 Cannabinoid Receptor Signaling"],"prefix":"10.3389","volume":"12","author":[{"given":"Robert B.","family":"Laprairie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawthar A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayat","family":"Zagzoog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie E. M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley A.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Pertwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Denovan-Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh A.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1074\/jbc.M111.316463","article-title":"Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi proteiindependent ERK1\/2 kinase activation.","volume":"287","author":"Ahn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1124\/jpet.303.1.340","article-title":"Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic \u03949-tetrahydrocannabinol administration.","volume":"303","author":"Anikwue","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ejphar.2013.09.002","article-title":"Co-expression of thehuman cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes.","volume":"721","author":"Bagher","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1124\/mol.112.080879","article-title":"CB1 receptor allosteric modulators display both agonist and signaling pathway specificity.","volume":"83","author":"Baillie","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/s1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors.","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism.","volume":"220","author":"Black","year":"1983","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/j.1476-5381.2011.01503.x","article-title":"AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.","volume":"165","author":"Bolognini","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1476-5381.2010.00756.x","article-title":"The plant cannabinoid \u03949-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.","volume":"160","author":"Bolognini","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/acs.jmedchem.5b00579","article-title":"Distinct temporal fingerprint for cyclic adenosine monophosphate (cAMP) signaling of indole-2-carboxamides as allosteric modulators of the cannabinoid receptors.","volume":"58","author":"Cawston","year":"2015","journal-title":"J. Med. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/bph.12329","article-title":"Real-time characterization of cannabinoid receptor 1 (CB1) allosteric modulators reveals novel mechanism of action.","volume":"170","author":"Cawston","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cell.2013.10.042","article-title":"\u03949-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33873","DOI":"10.1074\/jbc.m112.352328","article-title":"A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org27569.","volume":"287","author":"Fay","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1006\/abbi.1998.1025","article-title":"Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.","volume":"362","author":"Fowler","year":"1999","journal-title":"Arch. Biochem. Biophys."},{"key":"B15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0773.1997.tb00291.x","article-title":"Ibuprofen inhibits the metabolism of the endogenous cannabimimetic agent anandamide.","volume":"80","author":"Fowler","year":"","journal-title":"Pharmacol. Toxicol."},{"key":"B16","first-page":"729","article-title":"Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.","volume":"283","author":"Fowler","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/bf03259953","article-title":"Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.","volume":"2","author":"Fowler","year":"1987","journal-title":"Med. Toxicol. Adverse Drug Exp."},{"key":"B18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropharm.2017.08.008","article-title":"The great divide: separation between in vitro and in vivo effects of PSNCBAM-based CB1 receptor allosteric modulators.","volume":"125","author":"Gamage","year":"2017","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"32442","DOI":"10.1074\/jbc.m502563200","article-title":"Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.","volume":"280","author":"Hata","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2007.02.051","article-title":"Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.","volume":"565","author":"Holt","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1.","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1476-5381.2010.00681.x","article-title":"Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors.","volume":"160","author":"Hudson","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1021\/jm060446b","article-title":"Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen\/lysine3.28(192) interaction.","volume":"49","author":"Hurst","year":"2006","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1021\/acsmedchemlett.9b00256","article-title":"Identification of CB1 receptor allosteric sites using fore-biased MMC simulated annealing and validation by structure-activity studies.","volume":"10","author":"Hurst","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects.","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1002\/jcc.21794","article-title":"Parameterization of Org27569: an allosteric modulator of the cannabinoid CB1 G protein-coupled receptor.","volume":"32","author":"Iliff","year":"2011","journal-title":"J. Comput. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology.","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nmeth978","article-title":"A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer.","volume":"3","author":"James","year":"2006","journal-title":"Nat. Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"D387","DOI":"10.1093\/nar\/gkn750","article-title":"The SWISS-MODEL repository and associated resources.","volume":"37","author":"Kiefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.","volume":"29","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.","volume":"289","author":"Laprairie","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor.","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2019.03.033","article-title":"Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington\u2019s disease in the R6\/2 mouse model.","volume":"151","author":"Laprairie","year":"2019","journal-title":"Neuropharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor.","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41401-018-0164-x","article-title":"Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor.","volume":"40","author":"Lu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity.","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejphar.2005.12.015","article-title":"The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.","volume":"531","author":"Ottani","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"21134","DOI":"10.1073\/pnas.1202906109","article-title":"Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.","volume":"109","author":"Pamplona","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11095-006-9905-5","article-title":"Brain uptake on nonsteroidal anti-inflammatory drugs: ibuprofen, flurbiprofen, and indomethacin.","volume":"23","author":"Parepally","year":"2006","journal-title":"Pharm. Res."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep10541","article-title":"Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: involvement of cannabinoid CB1 receptors.","volume":"5","author":"Parvathy","year":"2015","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1369-1600.2008.00108.x","article-title":"Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.","volume":"13","author":"Pertwee","year":"2008","journal-title":"Addict. Biol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor.","volume":"68","author":"Price","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1096\/fj.14-263053","article-title":"A potential role for cannabinoid receptors in the therapeutic action of fenofibrate.","volume":"29","author":"Priestley","year":"2015","journal-title":"FASEB J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1073\/pnas.1033060100","article-title":"The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.","volume":"100","author":"Reid","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1124\/dmd.32.1.113","article-title":"Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenehtylamide in rat, mouse, and human liver microsomes: identification of active metabolites.","volume":"32","author":"Remmel","year":"2004","journal-title":"Drug Met. Dispos."},{"key":"B47","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.tips.2007.10.006","article-title":"Allosterism and cannabinoid CB(1) receptors: the shape of things to come.","volume":"28","author":"Ross","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.bjp.0702836","article-title":"Structural determinants of the partial agonist-inverse agonist properties of 6\u2032-azidohex-2\u2032-yne-\u03948-tetrahydrocannabinol at cannabinoid receptors.","volume":"128","author":"Ross","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.bjp.0704973","article-title":"Molecular pharmacology of the human prostaglandin D2 receptor. CRTH2.","volume":"137","author":"Sawyer","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1074\/jbc.M113.478495","article-title":"Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling.","volume":"289","author":"Shore","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence.","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/mol.118.111864","article-title":"Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons.","volume":"94","author":"Straiker","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2005.09.005","article-title":"CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.","volume":"524","author":"Sugimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.","volume":"176","author":"Tham","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading.","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.lfs.2006.08.017","article-title":"Evaluation of the role of the arachidonic acid cascade in anandamide\u2019s in vivo effects in mice.","volume":"80","author":"Wiley","year":"2006","journal-title":"Life Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0006-8993(00)03127-9","article-title":"Behavioural suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats.","volume":"889","author":"Yamamguchi","year":"2001","journal-title":"Brain Res."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00257\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T04:38:13Z","timestamp":1571373493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2019.00257\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":57,"alternative-id":["10.3389\/fnmol.2019.00257"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2019.00257","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"article-number":"257"}}